Evaluation of a fast and fully automated platform to diagnose <i>EGFR</i> and <i>KRAS</i> mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day

Abstract

The Idylla platform is an interesting ancillary first-line fast and fully automated tool to detect <i>EGFR</i> and <i>KRAS</i> mutations in NSCLC samples allowing rapid treatment choices in patients with acute deterioration.